BackgroundCheck.run
Search For

Timothy A Leaf, 595933 Bellflower Dr, Newark, CA 94560

Timothy Leaf Phones & Addresses

5933 Bellflower Dr, Newark, CA 94560    510-7907641   

Saint Paul, MN   

Newton, MA   

Roxbury Crossing, MA   

Framingham, MA   

Alameda, CA   

5933 Bellflower Dr, Newark, CA 94560    510-8674768   

Work

Position: Professional Specialty Occupations

Education

Degree: Associate degree or higher

Mentions for Timothy A Leaf

Timothy Leaf resumes & CV records

Resumes

Timothy Leaf Photo 12

Recreational Facilities And Services Professional

Location:
Greater Minneapolis-St. Paul Area
Industry:
Recreational Facilities and Services
Timothy Leaf Photo 13

Owner, Leaf & Associates

Location:
Greater Minneapolis-St. Paul Area
Industry:
Broadcast Media
Timothy Leaf Photo 14

Manager, Fermentation Services At Amyris Biotechnologies

Location:
San Francisco Bay Area
Industry:
Biotechnology

Publications & IP owners

Us Patents

17-Allylamino-17-Demethoxygeldanamycin Polymorphs And Formulations

US Patent:
7648976, Jan 19, 2010
Filed:
Nov 8, 2006
Appl. No.:
11/595005
Inventors:
Peter J. Licari - Fremont CA, US
Timothy Leaf - Newark CA, US
Ruchir P. Desai - Foster City CA, US
Jorge L. Galazzo - Sunnyvale CA, US
Greg O. Buchanan - Hayward CA, US
Stephen William Watt - Chatteris, GB
Alexander Redvers Eberlin - Cambridge, GB
Robert Arslanian - Lafayette CA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 225/04
C07D 225/06
A61K 9/00
US Classification:
514183, 540463
Abstract:
Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxygeldanamycin (17-AAG).

Method Of Producing A Compound By Fermentation

US Patent:
2005013, Jun 16, 2005
Filed:
Aug 6, 2004
Appl. No.:
10/913180
Inventors:
Timothy Leaf - Newark CA, US
Ruchir Desai - Foster City CA, US
Peter Licari - Fremont CA, US
Elaine Woo - Jackson FL, US
Assignee:
Kosan Biosciences, Inc. - Hayward CA
International Classification:
C12N009/00
US Classification:
435183000
Abstract:
During the production of a product compound by fermentation, the concentration of a precursor compound is maintained within a pre-selected concentration range by having an adsorbent resin in contact with the culture medium. The adsorbent resin reversibly adsorbs precursor compound and, as un-adsorbed precursor compound is converted to product compound, adsorbed precursor compound is released from the resin, thus maintaining the concentration of precursor compound within the pre-selected range.

17-Allylamino-17-Demethoxygeldanamycin Polymorphs And Formulations

US Patent:
2009004, Feb 12, 2009
Filed:
May 29, 2008
Appl. No.:
12/129369
Inventors:
Peter J. Licari - Hayward CA, US
Timothy Leaf - Newark CA, US
Ruchir P. Desai - Foster City CA, US
Jorge L. Galazzo - Sunnyvale CA, US
Greg O. Buchanan - Hayward CA, US
Stephen William Watt - Chatteris, GB
Alexander Redvers Eberlin - Cambridge, GB
Robert Arslanian - Pacifica CA, US
Assignee:
Kosan Biosciences Incorporated - Hayward CA
International Classification:
A61K 31/395
C07D 225/06
US Classification:
514183, 540461
Abstract:
Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxy-geldanamycin (17-AAG).

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.